News Agency
The Times

Keymed Biosciences Announces Interim Results for First Half of 2024

  • Written by PR Newswire

CHENGDU, China , Aug. 27, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced its interim results for the first half of 2024, along with a corporate update. 

Rapid development of our pipeline products

Stapokibart (CM310) (IL-4Rα antibody)

  • In June 2024, the long-term efficacy and safety data from the Phase III...

Read more: Keymed Biosciences Announces Interim Results for First Half of 2024

Google Ads Agency Sydney: How to Generate More Qualified Leads With Paid Search

When someone searches Google for a service they need immediately, appearing at the right moment can be extremely valuable. Unlike many traditional marketing channels, paid search can place a business in front of people who are already researching a product... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion